Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 866 entries
View as:

A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy

Phase: N/A Priority: Normal
NCT ID: NCT04958031 Org: User:
Start: 06/22/21 End: 02/13/25 Due: 02/13/26

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03653026 Org: User:
Start: 12/06/18 End: 01/14/21 Due: 01/14/22

Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor

Phase: N/A Priority: Normal
NCT ID: NCT05216250 Org: User:
Start: 04/12/22 End: 02/03/25 Due: 02/03/26

A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03017014 Org: User:
Start: 09/26/17 End: 10/14/19 Due: 10/14/20

Study to Assess Adverse Events and Compare How Two Subcutaneous ABBV-154 Injection Formulations Move Through the Body of Adult Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05556226 Org: User:
Start: 10/18/22 End: 02/17/23 Due: 02/17/24

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00788684 Org: User:
Start: 07/21/09 End: 02/07/25 Due: 02/07/26

Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service

Phase: N/A Priority: Normal
NCT ID: NCT03223012 Org: User:
Start: 11/15/17 End: 02/28/19 Due: 02/28/20

A Study to Assess Adverse Events and Effectiveness of Injected JUVÉDERM® VOLITE™ Gel Filler for Change in Neck Lines in Adult Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT05741034 Org: User:
Start: 04/07/23 End: 12/09/24 Due: 12/09/25

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03646604 Org: User:
Start: 01/31/19 End: 08/29/24 Due: 08/29/25

A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03595059 Org: User:
Start: 07/13/18 End: 06/30/25 Due: 06/30/26

A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03398148 Org: User:
Start: 03/07/18 End: 05/11/23 Due: 05/11/24

A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05644977 Org: User:
Start: 12/02/22 End: 04/14/25 Due: 04/14/26

A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib

Phase: N/A Priority: Normal
NCT ID: NCT05451316 Org: User:
Start: 12/08/22 End: 12/31/24 Due: 12/31/25

An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications

Phase: N/A Priority: Normal
NCT ID: NCT02082249 Org: User:
Start: 03/10/14 End: 10/31/19 Due: 10/31/20

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05995353 Org: User:
Start: 12/11/23 End: 04/30/29 Due: 04/30/30

A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02499263 Org: User:
Start: 06/11/15 End: 09/17/18 Due: 09/17/19

An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)

Phase: N/A Priority: Normal
NCT ID: NCT05959070 Org: User:
Start: 11/09/23 End: 03/21/25 Due: 03/21/26

Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06605599 Org: User:
Start: 10/15/24 End: 04/30/26 Due: 04/30/27

A Study to Assess Prevalence of a Specific Protein Overexpression in Adult Participants With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06068842 Org: User:
Start: 11/03/23 End: 12/31/24 Due: 12/31/25

Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT06068868 Org: User:
Start: 11/13/23 End: 02/25/25 Due: 02/25/26

Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT04818385 Org: User:
Start: 05/31/21 End: 02/28/26 Due: 02/28/27

A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02880956 Org: User:
Start: 01/26/17 End: 07/28/21 Due: 07/28/22

Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05368558 Org: User:
Start: 08/18/22 End: 09/20/24 Due: 09/20/25

A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01933919 Org: User:
Start: 08/14/13 End: 07/01/16 Due: 07/01/17

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

Phase: N/A Priority: Normal
NCT ID: NCT06682988 Org: User:
Start: 05/28/25 End: 02/28/29 Due: 02/28/30